Inhibrx Biosciences, Inc.INBXNASDAQ
LOADING
|||
Cash Flow Performance
Trending lower, below historical average, strong compound growth.
Left:
||||
Free cash flow yield
Latest
-88.37%
↓ 482% below average
Average (8y)
-15.19%
Historical baseline
Range
High:-2.43%
Low:-88.37%
CAGR
+56.7%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | -88.37% | -699.7% |
| 2023 | -11.05% | +5.8% |
| 2022 | -11.74% | -140.0% |
| 2021 | -4.89% | +17.4% |
| 2020 | -5.92% | -31.8% |
| 2019 | -4.49% | -2.4% |
| 2018 | -4.39% | -29.8% |
| 2017 | -3.38% | -39.2% |
| 2016 | -2.43% | - |